Jean-Sébastien Cleiftie
Director/Board Member chez BioVex, Inc.
Profil
Jean-Sébastien Cleiftie is a professional with a Master's in Business Administration from Cornell University and a graduate degree from Université de Paris 5 René Descartes.
He is currently a Director at BioVex, Inc. and has previously worked as a Director at BioVex Group, Inc., Kiora Pharmaceuticals, Inc., and.
BioVex Ltd.
He was also a Principal at Innoven Partners from 2004 to 2010.
From 2010 to 2016, he worked as an Associate VP-Global Business Development at Sanofi.
He was the Chief Business Officer at ERYTech Pharma SA from 2016 to 2021.
Postes actifs de Jean-Sébastien Cleiftie
| Sociétés | Poste | Début |
|---|---|---|
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Director/Board Member | - |
Anciens postes connus de Jean-Sébastien Cleiftie
| Sociétés | Poste | Fin |
|---|---|---|
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Corporate Officer/Principal | 01/11/2021 |
| SANOFI | Corporate Officer/Principal | 01/08/2016 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Director/Board Member | 24/01/2013 |
PC Associés SAS
 PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Private Equity Analyst | 01/12/2010 |
Innoven Partners
 Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Corporate Officer/Principal | 01/10/2010 |
Formation de Jean-Sébastien Cleiftie
| Cornell University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANOFI | Health Technology |
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
PC Associés SAS
PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Finance |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Innoven Partners
Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Finance |
